Patents by Inventor Luisa Yee

Luisa Yee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9539233
    Abstract: A method and composition for treatment of bacterial infections caused by gram negative or gram positive bacteria such as Staphylococcus aureus, Rhodococcus equi, Mycobacterium tuberculosis, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug resistant Pseudomonas aeruginosa, using a formulation containing gallium (III), in a pharmaceutically acceptable salt or complex thereof.
    Type: Grant
    Filed: May 3, 2010
    Date of Patent: January 10, 2017
    Assignee: Aridis Pharmaceuticals Inc.
    Inventors: Satoshi Ohtake, Vu Truong-Le, David Lechuga-Ballesteros, Luisa Yee, Binh Pham, Russell Martin, Atul Saxena
  • Publication number: 20160051660
    Abstract: Methods and compositions for the optimization of production of influenza viruses suitable as influenza vaccines are provided.
    Type: Application
    Filed: March 4, 2015
    Publication date: February 25, 2016
    Inventors: George Robert TRAGER, Richard M. Schwartz, Vu Truong-Le, Luisa Yee, John Michael Berry, Weidong Cui
  • Patent number: 8986705
    Abstract: Methods and compositions for the optimization of production of influenza viruses suitable as influenza vaccines are provided.
    Type: Grant
    Filed: February 27, 2013
    Date of Patent: March 24, 2015
    Assignee: MedImmune, LLC
    Inventors: George Robert Trager, Vu Truong-Le, Luisa Yee
  • Patent number: 8673357
    Abstract: This invention provides methods of spray drying pharmaceutical powders from a vibrating nozzle at low pressures. The method can effectively spray dry thick or viscous solutions or suspensions to provide small uniform particles. The invention includes dry particle compositions prepared by methods of low pressure spraying from vibrating nozzles.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: March 18, 2014
    Assignee: Aridis Pharmaceuticals
    Inventors: Vu Truong-Le, Satoshi Ohtake, Russell Andrew Martin, Binh V. Pham, Luisa Yee
  • Patent number: 8637090
    Abstract: A method and composition for treatment of bacterial infections caused by gram negative or gram positive bacteria such as Staphylococcus aureus, Rhodococcus equi, Mycobacterium tuberculosis, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug resistant Pseudomonas aeruginosa, using a formulation containing gallium (III), in a pharmaceutically acceptable salt or complex thereof.
    Type: Grant
    Filed: May 4, 2010
    Date of Patent: January 28, 2014
    Assignee: Aridis Pharmaceuticals
    Inventors: Satoshi Ohtake, Vu Truong-Le, David Lechuga-Ballesteros, Luisa Yee, Binh V Pham, Russell Martin, Atul Saxena
  • Publication number: 20120308526
    Abstract: This invention provides methods of spray drying pharmaceutical powders from a vibrating nozzle at low pressures. The method can effectively spray dry thick or viscous solutions or suspensions to provide small uniform particles. The invention includes dry particle compositions prepared by methods of low pressure spraying from vibrating nozzles.
    Type: Application
    Filed: August 14, 2012
    Publication date: December 6, 2012
    Applicant: Aridis Pharmaceuticals
    Inventors: Satoshi Ohtake, Russell Andrew Martin, Binh Pham, Luisa Yee
  • Patent number: 8268354
    Abstract: This invention provides methods of spray drying pharmaceutical powders from a vibrating nozzle at low pressures. The method can effectively spray dry thick or viscous solutions or suspensions to provide small uniform particles. The invention includes dry particle compositions prepared by methods of low pressure spraying from vibrating nozzles.
    Type: Grant
    Filed: November 6, 2008
    Date of Patent: September 18, 2012
    Assignee: Aridis Pharmaceuticals
    Inventors: Vu Truong-Le, Satoshi Ohtake, Russell Andrew Martin, Binh V. Pham, Luisa Yee
  • Patent number: 8241886
    Abstract: This invention provides formulations and methods for stabilizing viruses in liquid and dried formulations. In particular, formulations are provided including Zn2+ cations that stabilize the viability of Rotaviruses. Methods of vaccination include neutralization of gastric contents and administration of the vaccine formulations of the invention.
    Type: Grant
    Filed: September 24, 2008
    Date of Patent: August 14, 2012
    Assignee: Aridis Pharmaceuticals
    Inventors: Vu Truong-Le, Luisa Yee, David Lechuga-Ballesteros, Satoshi Ohtake
  • Publication number: 20120148635
    Abstract: A method and composition for treatment of bacterial infections caused by gram negative or gram positive bacteria such as Staphylococcus aureus, Rhodococcus equi, Mycobacterium tuberculosis, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug resistant Pseudomonas aeruginosa, using a formulation containing gallium (III), in a pharmaceutically acceptable salt or complex thereof.
    Type: Application
    Filed: May 4, 2010
    Publication date: June 14, 2012
    Applicant: Aridis Pharmaceuticals
    Inventors: Satoshi Ohtake, Vu Truong-Le, David Lechuga-Ballesteros, Luisa Yee, Binh V. Pham, Russel Martin, Atul Saxena
  • Publication number: 20120128729
    Abstract: A method and composition for treatment of bacterial infections caused by gram negative or gram positive bacteria such as Staphylococcus aureus, Rhodococcus equi, Mycobacterium tuberculosis, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug resistant Pseudomonas aeruginosa, using a formulation containing gallium (III), in a pharmaceutically acceptable salt or complex thereof.
    Type: Application
    Filed: May 3, 2010
    Publication date: May 24, 2012
    Inventors: Satoshi Ohtake, David Lechuga-Ballesteros, Vu Truong-Le, Luisa Yee, Binh V. Pham, Russell Martin, Atul Saxena
  • Publication number: 20110243988
    Abstract: This invention provides compositions and methods for stabilizing a live attenuated virus in dried formulations. In particular, compositions and methods of preparing a dried vaccine are provided that stabilize the viability of live vaccines such as measles and adenovirus at room temperature.
    Type: Application
    Filed: October 1, 2010
    Publication date: October 6, 2011
    Inventors: Satoshi Ohtake, Vu Truong-Le, Luisa Yee, Russell A. Martin, David Lechuga-Ballesteros
  • Publication number: 20100331428
    Abstract: This invention provides methods of spray drying pharmaceutical powders from a vibrating nozzle at low pressures. The method can effectively spray dry thick or viscous solutions or suspensions to provide small uniform particles. The invention includes dry particle compositions prepared by methods of low pressure spraying from vibrating nozzles.
    Type: Application
    Filed: November 6, 2008
    Publication date: December 30, 2010
    Applicant: ARIDIS PHARMACEUTICALS
    Inventors: Vu Truong-Le, Satoshi Ohtake, Russell Andrew Martin, Binh Pham, Luisa Yee
  • Publication number: 20100226939
    Abstract: This invention provides formulations and methods for stabilizing viruses in liquid and dried formulations. In particular, formulations are provided including Zn2+ cations that stabilize the viability of Rotaviruses. Methods of vaccination include neutralization of gastric contents and administration of the vaccine formulations of the invention.
    Type: Application
    Filed: September 24, 2008
    Publication date: September 9, 2010
    Inventors: Vu Truong-Le, Luisa Yee, David Lechuga-Ballesteros, Satoshi Ohtake
  • Publication number: 20090246225
    Abstract: Methods and compositions for the optimization of production of influenza viruses suitable as influenza vaccines are provided.
    Type: Application
    Filed: December 8, 2008
    Publication date: October 1, 2009
    Applicant: MedImmune, LLC
    Inventors: George Robert Trager, George Kemble, Richard M. Schwartz, Harshvardhan Mehta, Vu Truong-Le, Zhongying Chen, Alfred A. Pan, Eric Tsao, Chiaoyin Kathy Wang, Luisa Yee, Palani Balu
  • Publication number: 20070161085
    Abstract: Methods and compositions for the optimization of production of influenza viruses suitable as influenza vaccines are provided.
    Type: Application
    Filed: January 30, 2007
    Publication date: July 12, 2007
    Applicant: Medlmmune Vaccines, Inc.
    Inventors: George Trager, George Kemble, Richard Schwartz, Harshvardhan Mehta, Vu Truong-Le, Zhongying Chen, Alfred Pan, Eric Tsao, Chiaoyin Wang, Luisa Yee, Palani Balu
  • Publication number: 20040265987
    Abstract: Methods and compositions for the optimization of production of influenza viruses suitable as influenza vaccines are provided.
    Type: Application
    Filed: February 25, 2004
    Publication date: December 30, 2004
    Applicant: Medlmmune Vaccines, Inc.
    Inventors: George Robert Trager, George Kemble, Richard M. Schwartz, Harshvardhan Mehta, Vu Truong-Le, Zhongying Chen, Alfred A. Pan, Eric Tsao, Chiaoyin Kathy Wang, Luisa Yee, Palani Balu